Skip to content

Clinical trials

Phase 1/2 Ovarian Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ovarian Neoplasms Phase: Phase 1/2 Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20161
20181
20192
20202
20215
20221
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting6
Active, not recruiting5
Unknown status2
Completed1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca5
Asan Medical Center1
BicycleTx Limited1
CanariaBio Inc.1
Eli Lilly and Company1
Medicenna Therapeutics, Inc.1
NGM Biopharmaceuticals, Inc1
PMV Pharmaceuticals, Inc1
Regeneron Pharmaceuticals1
Revolution Medicines, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ovarian Neoplasms14
Endometrial Neoplasms7
Breast Neoplasms6
Carcinoma, Non-Small-Cell Lung6
Colorectal Neoplasms6
Stomach Neoplasms5
Pancreatic Neoplasms4
Urinary Bladder Neoplasms4
Uterine Cervical Neoplasms4
Fallopian Tube Neoplasms3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.